Profil organizatora
Barigen 4 mg (Baricitinib)
Barigen 4 mg, containing Baricitinib, is a medication used primarily for the treatment of moderate to severe rheumatoid arthritis in adults who have had an inadequate response to one or more TNF antagonist therapies. Baricitinib works by inhibiting Janus kinase (JAK) enzymes, which play a key role in the inflammatory process associated with rheumatoid arthritis. This reduction in inflammation helps to decrease symptoms such as pain, swelling, and joint damage. Barigen is typically administered orally once daily, with or without food. It's important for patients to follow their healthcare provider's instructions and attend regular check-ups to monitor their condition and any potential side effects.
0
razy użytkownik wpłacił na zrzutki
Dołączył/a
2 lipca 2024
Inna nazwa (firma, fundacja..)
Barigen 4 mg (Baricitinib)
